findmyKOL
Clinical trialNCT07103018RecruitingPhase 1Interventional

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

SponsorK36 Therapeutics, Inc.Enrollment144Metastatic Castration-Resistant Prostate Cancer PatientsMetastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer, mCRPCmCRPCmCRPC (Metastatic Castration-resistant Prostate Cancer)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California San Francisco

    San Francisco, California, United States

    Ivan de Kouchkovsky, MD
    Recruiting
  • Sylvester Comprehensive Cancer Center

    Miami, Florida, United States

    Marijo Bilusic, MD, PhD
    Recruiting
  • Hematology Oncology Associates of the Treasure Coast

    Port Saint Lucie, Florida, United States

    Seth Rosen, MD
    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Elisabeth Heath, MD
    Recruiting
  • Start New York Long Island, Llc

    New Hyde Park, New York, United States

    Geraldine O'Sullivan Coyne, MD, PhD
    Recruiting
  • Columbia University Irving Medical Center

    New York, New York, United States

    Alexander Wei, MD
    Recruiting
  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

    Wassim Abida, MD, PhD
    Recruiting
  • Nyu Langone Health

    New York, New York, United States

    David Wise, MD
    Recruiting
  • Duke Cancer Center

    Durham, North Carolina, United States

    Hannah McManus, MD
    Recruiting
  • the Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

    Fuat Bicer, MD, PhD
    Not, yet, recruiting
  • Carolina Urologic Research Center, the Start Center for Cancer Research

    Myrtle Beach, South Carolina, United States

    Neal Shore, MD, FACS
    Recruiting
  • Usa Clinical Trials

    San Antonio, Texas, United States

    Jose De La Cerda, III, MD
    Recruiting
  • University of Wisconsin

    Madison, Wisconsin, United States

    Anthony Serritella, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

KTX-2001KTX-2001 + Darolutamide
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Nov 2025
Primary completion
30 Sept 2027
Completion
30 Sept 2028
Last update posted
9 Jul 2026
Registered enrollment
144
Registry id
NCT07103018

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.